Prevalence and predictors of multidrug-resistant bacteremia in liver cirrhosis
Aryoung Kim, Byeong Geun Song, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Myung Ji Goh
Korean J Intern Med. 2024;39(3):448-457. Published online 2024 Apr 30 DOI: https://doi.org/10.3904/kjim.2023.354
Citations to this article as recorded by 
Global Trends in Antimicrobial Resistance Among Cirrhosis Patients With Bacteremia: A Systematic Review and Meta-analysis
Ellis K. Paintsil, Cynthia K. Adu-Asiamah, Victoria T. Kronsten, Yevedzo Ntuli, Debbie L. Shawcross
Clinical Gastroenterology and Hepatology.2026; 24(1): 69. CrossRef
Burden and distribution of multidrug-resistant bacteria among hospitalized patients with cirrhosis: A systematic review and meta-analysis
Leonardo Corrêa Süffert, Enzo Arthur Bruno Pergher, Henrique Steffens de Abreu, Eliabe S. Abreu, Luis Pedro Possapp Beis, Isabella Heringer Padilha, Bernardo de Faria Moraes, Pedro Robson Costa Passos, Luisa Medeiros Visentini, Frederico Friedrich, Diego
Clinics and Research in Hepatology and Gastroenterology.2026; 50(7): 102877. CrossRef
Antibiotics in decompensated liver disease – who, when and for how long?
Frederic Haedge, Tony Bruns
Expert Review of Gastroenterology & Hepatology.2025; 19(2): 111. CrossRef
Multidrug-resistant bacterial infections in cirrhotic ICU patients in a tertiary care center: a post-pandemic study
Ahmed R. Riad, Elham Ahmed Hassan, Abeer Sharaf El-Din Abdel Rehim, Mohamed Eltaher Ibrahim, Asmaa Omar Ahmed, Mohamed E. Ali, Karima A. Mostafa
The Egyptian Journal of Internal Medicine.2025;[Epub] CrossRef
Decompensated cirrhosis and antibiotic prophylaxis: striking a delicate balance
Jung Gil Park
The Korean Journal of Internal Medicine.2024; 39(3): 369. CrossRef